Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Gladstone and UCSF researcher has been awarded the Nobel Prize for Medicine for his discovery that ordinary human cells can be reprogrammed into stem cells, possibly leading to new breakthrough medical treatments.
Shinya Yamanaka of Japan and John Gurdon of Britain shared the 2012 Nobel Prize in Physiology or Medicine "for the discovery that mature cells can be reprogrammed to become pluripotent," the Nobel Assembly at Karolinska Institutet in Stockholm said Monday.
Japan started the 2012 Nobel Prize season off with a bang, as a wunderkind 50-year-old star scientist shared honors Monday in physiology/medicine, the first of the medals to be awarded this year.
John B. Gurdon transferred DNA between a tadpole and a frog to clone the first animal. Shinya Yamanaka used Gurdon’s concept to turn ordinary skin into potent stem cells. Both won the Nobel Prize for medicine today.
Sir John Gurdon shares the Nobel prize in physiology or medicine with Shinya Yamanaka, for reprogramming adult cells
England's Sir John Gurdon and Dr. Shinya Yamanaka from Japan share the 2012 Nobel Prize in medicine for work on stem cells, revealing that mature cells can be reverted into primitive cells.
John B. Gurdon of the U.K. and Shinya Yamanaka of Japan shared this year's Nobel Prize in Physiology or Medicine for their work in so-called cellular reprogramming, which has unleashed a wave of advances in everything from cloning to the possible treatment of diseases using stem cells.
Gladstone researchers say the discovery could have a profound impact on how we treat hearts and heart disease.
Retired Senior Investigator Karl Weisgraber has had a long, difficult recovery from a fall off a ladder that caused a traumatic brain injury last October.
Scientists at the Gladstone Institutes have created the first "genomic blueprint" of the human heart, unveiling the exact order and timing of genetic events that must take place for an embryonic heart cell to become a beating, life-sustaining organ.